Research and Markets: Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3zrd8w/trends) has announced the addition of the "Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market" report to their offering.

This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients' adherence to treatment by offering one weekly drug dose for managing the chronic disease. This deliverable includes information regarding market background, dynamics, challenges, trends, and access. The base year is 2013. Also, provided are a detailed analysis of products on the market and in development within Latin America, as well as clinical trial details and projected drugs launch timelines.

Market Background

- Diabetes is a chronic progressive disease of the endocrine system in which, during themetabolism of carbohydrates, the body is unable to maintain and control the blood glucoselevel.

- Chronic exposure to elevated glucose can eventually lead to microvascular complications,such as peripheral neuropathy (nerve damage), nephropathy (kidney disease), retinopathy (vision loss), macrovascular complications (cardiovascular disease), and death.

- Type 2 diabetes usually presents in adolescent and adult patients, as opposed to type 1 diabetes that is a juvenile-onset chronic autoimmune disease. Type 2 diabetes is strongly associated with obesity, which is the main risk factor.

- Other risk factors include age, family history, inactivity, history of gestational diabetes, and race/ethnicity.

- The goal of diabetes treatment is to maintain glucose levels that are as close to normal as possible without risking hypoglycemia as a way to prevent or delay complications and death.

Key Topics Covered

1. Methodology and Scope

2. Executive Summary - Key Findings

3. Introduction

4. Competitive Analysis

5. Insulin Therapeutics Competitive Analysis - Marketed Products

6. Insulin Therapeutics Competitive Analysis - Ongoing Clinical Trials

7. Insulin Therapeutics Market Discussion

8. Non-insulin Therapeutics Competitive Analysis - Marketed Products

9. Non-insulin Therapeutics Competitive Analysis - Ongoing Clinical Trials

10. Non-insulin Therapeutics Market Discussion

11. Conclusions and Recommendations

12. The Frost & Sullivan Story

For more information visit http://www.researchandmarkets.com/research/3zrd8w/trends

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals